These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9881837)

  • 1. An ataxia telangiectasia model: inefficient cell differentiation and possible reversal by serine protease inhibitors, tumor necrosis factor inhibitors, dexamethasone, and glutathione enhancers.
    Knittweis J
    Med Hypotheses; 1998 Jul; 51(1):53-7. PubMed ID: 9881837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response.
    Biagiotti S; Menotta M; Orazi S; Spapperi C; Brundu S; Fraternale A; Bianchi M; Rossi L; Chessa L; Magnani M
    FEBS J; 2016 Nov; 283(21):3962-3978. PubMed ID: 27636396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain edema with clasmatodendrosis complicating ataxia telangiectasia.
    Shimoda K; Mimaki M; Fujino S; Takeuchi M; Hino R; Uozaki H; Hayashi M; Oka A; Mizuguchi M
    Brain Dev; 2017 Aug; 39(7):629-632. PubMed ID: 28351596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
    Piret B; Schoonbroodt S; Piette J
    Oncogene; 1999 Apr; 18(13):2261-71. PubMed ID: 10327072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells.
    Rahman I
    Biochem Pharmacol; 2000 Oct; 60(8):1041-9. PubMed ID: 11007940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha.
    Jung M; Zhang Y; Lee S; Dritschilo A
    Science; 1995 Jun; 268(5217):1619-21. PubMed ID: 7777860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor erythroid 2-related factor 2-antioxidant activation through the action of ataxia telangiectasia-mutated serine/threonine kinase is essential to counteract oxidative stress in bovine mammary epithelial cells.
    Ma YF; Wu ZH; Gao M; Loor JJ
    J Dairy Sci; 2018 Jun; 101(6):5317-5328. PubMed ID: 29605311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?
    Rotman G; Shiloh Y
    Bioessays; 1997 Oct; 19(10):911-7. PubMed ID: 9363685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
    Menotta M; Biagiotti S; Spapperi C; Orazi S; Rossi L; Chessa L; Leuzzi V; D'Agnano D; Soresina A; Micheli R; Magnani M
    Orphanet J Rare Dis; 2017 Jul; 12(1):126. PubMed ID: 28679388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ATM mutations with ataxia-telangiectasia.
    Liu XL; Wang T; Huang XJ; Zhou HY; Luan XH; Shen JY; Chen SD; Cao L
    Neurosci Lett; 2016 Jan; 611():112-5. PubMed ID: 26628246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells.
    Yan HQ; Zhang D; Shi YY; You X; Shi L; Li Q; Gao FG
    Oncotarget; 2016 Sep; 7(38):62070-62083. PubMed ID: 27556690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ataxia-telangiectasia].
    Kondo N; Fukuda K
    Nihon Rinsho; 2006 Sep; Suppl 3():114-8. PubMed ID: 17022512
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutation of ataxia-telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia.
    Campbell A; Bushman J; Munger J; Noble M; Pröschel C; Mayer-Pröschel M
    Glia; 2016 Feb; 64(2):227-39. PubMed ID: 26469940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia.
    Nissenkorn A; Ben-Zeev B
    Handb Clin Neurol; 2015; 132():199-214. PubMed ID: 26564081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
    Lavin MF
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):759-69. PubMed ID: 18813293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a dominant negative I kappa B-alpha modulates hypersensitivity of ataxia telangiectasia fibroblasts to streptonigrin-induced apoptosis.
    Jung M; Zhang Y; Dritschilo A
    Radiat Oncol Investig; 1997; 5(6):265-8. PubMed ID: 9436242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atm-deficient mice: a paradigm of ataxia telangiectasia.
    Barlow C; Hirotsune S; Paylor R; Liyanage M; Eckhaus M; Collins F; Shiloh Y; Crawley JN; Ried T; Tagle D; Wynshaw-Boris A
    Cell; 1996 Jul; 86(1):159-71. PubMed ID: 8689683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.
    Stewart R; Kozlov S; Matigian N; Wali G; Gatei M; Sutharsan R; Bellette B; Wraith-Kijas A; Cochrane J; Coulthard M; Perry C; Sinclair K; Mackay-Sim A; Lavin MF
    Hum Mol Genet; 2013 Jun; 22(12):2495-509. PubMed ID: 23474819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene.
    Meyn MS
    Clin Genet; 1999 May; 55(5):289-304. PubMed ID: 10422797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia-telangiectasia: A review of clinical features and molecular pathology.
    Amirifar P; Ranjouri MR; Yazdani R; Abolhassani H; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 May; 30(3):277-288. PubMed ID: 30685876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.